CSIMarket Company Name, Ticker, Industry, else..
 
Palisade Bio Inc   (NASDAQ: PALI)
 
Price: $2.1750 $0.09 4.067%
Day's High: $2.194999933242798 Week Perf: 10.97 %
Day's Low: $ 2.08 30 Day Perf: 3.08 %
Volume (M): 1,096,327 52 Wk High: $ 2.86
Volume (M$): $ 0 52 Wk Avg: $1.85
Open: $2.09 52 Wk Low: $0.53



 Market Capitalization (Millions $) 460
 Shares Outstanding (Millions) 211
 Employees 14
 Revenues (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) -32
 Cash Flow (TTM) (Millions $) 127
 Capital Exp. (TTM) (Millions $) 0

Business Description


Palisade Bio Inc is a biopharmaceutical company that focuses on the development and commercialization of novel therapies for patients with gastrointestinal (GI) diseases. The company's primary goal is to address the unmet medical needs in the GI space and improve the lives of patients suffering from these conditions. Palisade Bio Inc is committed to advancing innovative therapies through rigorous research and development, clinical trials, and collaboration with healthcare professionals. Their portfolio includes potential treatments for conditions like ulcerative colitis, Crohn's disease, and irritable bowel syndrome. The company aims to bring effective and safe therapies to patients worldwide and make a positive impact in the field of GI medicine.


   Company Address: 4600 South Syracuse Street, Suite 900 Denver 80237 CO
   Company Phone Number: 704-4900   Stock Exchange / Ticker: NASDAQ PALI


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
CGEM   -2.31%    
FENC        0.98% 
GILD        0.86% 
HALO        1.23% 
IMVT   -1.89%    
NMRA   -5.64%    
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 919.51
Price to Sales (Expected) -
Price to Book 3.78
PEG (TTM) -

Financial Strength Current
Quick Ratio 23.86
Working Capital Ratio 24.4
Leverage Ratio (MRQ) 0.05
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.64 $
Revenues (TTM) 0 $
Cash Flow (TTM) 0.6 $
Cash 0.59 $
Book Value 0.58 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 35,714
Net Income per Employee (TTM) -2,281,500
Receivable Turnover Ratio (TTM) 4
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0

Profitability Ratios Current
Gross Margin (MRQ) 0 %
Operating Margin (MRQ) -2339.6 %
Net Margin (MRQ) -2114.8 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Palisade Bio Inc's Segments





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.